Telemetric monitoring of pulmonary function after allogeneic hematopoietic stem cell transplantation

Transplantation. 2007 Mar 15;83(5):554-60. doi: 10.1097/01.tp.0000228236.55419.33.

Abstract

Background: Late-onset noninfectious pulmonary complications (LONIPC) are both frequent and severe after allogeneic hematopoietic stem cell transplantation (HSCT). The high mortality rate (40-80%) may be related to delayed diagnosis. We assessed the use of telemetric home surveillance of pulmonary function for early diagnosis of LONIPC in transplant recipients.

Methods: This prospective study monitored pulmonary function in 37 allogeneic HSCT recipients. About 3 months after HSCT, they received a portable spirometer that measured forced vital capacity, forced expiratory volume per second, and midexpiratory flow 25-75 (MEF25-75). Data were transmitted twice weekly by telephone. Conventional plethysmography confirmed any significant deterioration (>20%).

Results: Thirteen episodes of spirometric deterioration were detected by telemetry in 11 patients during a median 17-month (4-41) follow-up period after transplantation. In these cases, examinations including spirometry, high-resolution thoracic computed tomography and bronchoalveolar lavage diagnosed LONIPC in eight episodes in seven patients (cumulative incidence 23.4%, SE 0.08, at month 24 after transplant): bronchiolitis obliterans (BO, n=3), interstitial pneumonia (IP, n=4), or both BO and IP (n=1). Five episodes improved and three were stabilized with increased immunosuppressive therapy. At the last follow-up, of the seven patients with LONIPC, one successfully stopped immunosuppressive therapy, two were receiving low-dose mycophenolate mofetil, and four were receiving low-dose corticosteroid therapy. There were no cases of respiratory failure and no patient died from LONIPC.

Conclusion: Telemetric home monitoring of pulmonary function is a useful procedure for early diagnosis of LONIPC before clinical pulmonary symptoms and may improve outcome after allogeneic HSCT.

MeSH terms

  • Adult
  • Graft vs Host Disease / epidemiology
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Humans
  • Leukemia / drug therapy
  • Leukemia / therapy
  • Lung Diseases / diagnosis
  • Lung Diseases / diagnostic imaging
  • Lung Diseases / epidemiology*
  • Lung Diseases / etiology
  • Lymphocyte Count
  • Middle Aged
  • Monitoring, Physiologic
  • Multiple Myeloma / drug therapy
  • Multiple Myeloma / therapy
  • Paris
  • Prospective Studies
  • Radiography, Thoracic
  • Respiratory Function Tests*
  • Spirometry
  • Telemetry*
  • Transplantation, Homologous / physiology*